LogoLobbywatch

Roche Glycart AG

Pharmaceutique, SA, Schlieren

Données sur l'organisation
IDE registre du commerce
CHE-101.040.712
Description
The Roche Innovation Center Zurich (Roche Glycart AG) is active in the research and development of engineered therapeutic antibodies, with a focus on the fields of cancer immunotherapy and immunotherapy in general. Part of the Roche Group since 2005, it employs around 140 people.
Liendirect indirect

Soutenir Lobbywatch.ch

Soutenir Lobbywatch.ch? CCP 89-584470-6 IBAN CH9209000000895844706

Nous suivre

Newsletter